Blennow K - Search Results

1

Association of Vascular Risk Factors and Cerebrovascular Pathology With Alzheimer Disease Pathologic Changes in Individuals Without Dementia.

Lorenzini L, Maranzano A, Ingala S, Collij LE, Tranfa M, Blennow K, Di Perri C, Foley C, Fox NC, Frisoni GB, Haller S, Martinez-Lage P, Mollison D, O'Brien J, Payoux P, Ritchie C, Scheltens P, Schwarz AJ, Sudre CH, Tijms BM, Verde F, Ticozzi N, Silani V, Visser PJ, Waldman A, Wolz R, Chételat G, Ewers M, Wink AM, Mutsaerts H, Gispert JD, Wardlaw JM, Barkhof F. Lorenzini L, et al. Among authors: blennow k. Neurology. 2024 Oct 8;103(7):e209801. doi: 10.1212/WNL.0000000000209801. Epub 2024 Sep 17. Neurology. 2024. PMID: 39288341 Free PMC article.

2

Clinical heterogeneity of probable Alzheimer's disease.

Blennow K, Wallin A. Blennow K, et al. J Geriatr Psychiatry Neurol. 1992 Apr-Jun;5(2):106-13. doi: 10.1177/002383099200500208. J Geriatr Psychiatry Neurol. 1992. PMID: 1590911

3

Gangliosides in cerebrospinal fluid in 'probable Alzheimer's disease'.

Blennow K, Davidsson P, Wallin A, Fredman P, Gottfries CG, Karlsson I, Månsson JE, Svennerholm L. Blennow K, et al. Arch Neurol. 1991 Oct;48(10):1032-5. doi: 10.1001/archneur.1991.00530220048018. Arch Neurol. 1991. PMID: 1929894

4

Intrathecal synthesis of immunoglobulins in patients with Alzheimer's disease.

Blennow K, Wallin A, Fredman P, Gottfries CG, Karlsson I, Svennerholm L. Blennow K, et al. Eur Neuropsychopharmacol. 1990 Nov;1(1):79-81. doi: 10.1016/0924-977x(90)90017-5. Eur Neuropsychopharmacol. 1990. PMID: 2136219

5

Intra-blood-brain-barrier synthesis of immunoglobulins in patients with dementia of the Alzheimer type.

Blennow K, Wallin A, Davidsson P, Fredman P, Gottfries CG, Svennerholm L. Blennow K, et al. Alzheimer Dis Assoc Disord. 1990 Summer;4(2):79-86. Alzheimer Dis Assoc Disord. 1990. PMID: 2357340

6

White matter low attenuation on computed tomography in Alzheimer's disease and vascular dementia--diagnostic and pathogenetic aspects.

Wallin A, Blennow K, Uhlemann C, Långström G, Gottfries CG. Wallin A, et al. Among authors: blennow k. Acta Neurol Scand. 1989 Dec;80(6):518-23. doi: 10.1111/j.1600-0404.1989.tb03920.x. Acta Neurol Scand. 1989. PMID: 2618578

7

Clusterin (apolipoprotein J) protein levels are increased in hippocampus and in frontal cortex in Alzheimer's disease.

Lidström AM, Bogdanovic N, Hesse C, Volkman I, Davidsson P, Blennow K. Lidström AM, et al. Among authors: blennow k. Exp Neurol. 1998 Dec;154(2):511-21. doi: 10.1006/exnr.1998.6892. Exp Neurol. 1998. PMID: 9878186

8

Neurofilament protein levels in CSF are increased in dementia.

Rosengren LE, Karlsson JE, Sjögren M, Blennow K, Wallin A. Rosengren LE, et al. Among authors: blennow k. Neurology. 1999 Mar 23;52(5):1090-3. doi: 10.1212/wnl.52.5.1090. Neurology. 1999. PMID: 10102440

9

Cerebrospinal fluid beta-amyloid(1-42) in Alzheimer disease: differences between early- and late-onset Alzheimer disease and stability during the course of disease.

Andreasen N, Hesse C, Davidsson P, Minthon L, Wallin A, Winblad B, Vanderstichele H, Vanmechelen E, Blennow K. Andreasen N, et al. Among authors: blennow k. Arch Neurol. 1999 Jun;56(6):673-80. doi: 10.1001/archneur.56.6.673. Arch Neurol. 1999. PMID: 10369305

10

Cerebrospinal fluid markers of pathogenetic processes in vascular dementia, with special reference to the subcortical subtype.

Wallin A, Blennow K, Rosengren L. Wallin A, et al. Among authors: blennow k. Alzheimer Dis Assoc Disord. 1999 Oct-Dec;13 Suppl 3:S102-5. Alzheimer Dis Assoc Disord. 1999. PMID: 10609688 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,158 results

Search Page